Drug Discovery and Production - 10 Questions to Ask When Doing RNA-Seq Experiments
Can't see this email? View it online
   
  Drug Discovery and Production  
  The latest drug discovery news from News Medical  
 

Key Raw Materials for Cell and Gene Therapy Key Raw Materials for Cell and Gene Therapy

Cell and gene therapy is a novel therapy that has the potential to revolutionize cancer treatment. To support cell and gene therapy-related research, ACROBiosystems has developed a comprehensive series of cell and gene therapy related products, including 50+ target proteins, CRISPR-Cas nuclease, GMP grade cytokines, and anti-CD3/CD28 coupled magnetic beads. Their high-quality and consistent products can help accelerate your drug therapy development process.

Find Out More
 
 
    10 Questions to Ask When Doing RNA-Seq Experiments10 Questions to Ask When Doing RNA-Seq Experiments
 
A Guide to RNA-Seq from Azenta Life Sciences provides a detailed look at the science behind this powerful NGS tool, common RNA-Seq assays, and what questions to ask when choosing the right one. Achieve the best results for your research.
 
Download the eBook Today
 
 
   Advances in modeling molecular interactions needed to better harness AlphaFold for drug discoveryAdvances in modeling molecular interactions needed to better harness AlphaFold for drug discovery
 
Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.
 
   The use of AlphaFold2-enabled molecular docking simulations to predict protein-ligand interactions for antibiotic drug discoveryThe use of AlphaFold2-enabled molecular docking simulations to predict protein-ligand interactions for antibiotic drug discovery
 
Researchers demonstrated that advances in modeling protein-ligand interactions using machine learning-based approaches are needed to exploit AlphaFold2 for antibiotic discovery better.
 
   Clinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritisClinical trial shows efficacy and safety of belimumab in East Asian adults with lupus nephritis
 
This prespecified subgroup analysis of East Asian adults who participated in a phase 3 clinical trial of belimumab added to standard therapy vs. placebo added to standard therapy for lupus nephritis shows earlier and more sustained improvement in kidney outcomes with the addition of belimumab.